Boyds bolsters regulatory affairs team with key appointment
We are delighted to announce the appointment of experienced regulatory affairs professional and cell and gene therapy expert Dr Patrick Ginty. With 17 years’ R&D and regulatory affairs experience in regenerative medicine and cell and gene therapy products, Patrick joins Boyds as Senior Director of Regulatory Affairs. Most recently, Patrick was Head of Regulatory Affairs […]
